Clinical experiences with 6-monthly paliperidone palmitate beyond the diagnosis of schizophrenia. A retrospective study

被引：0
|
作者：
Lopez, S. Benavente [1 ]
Mendoza, S. Bolano [1 ]
Gonzalez, A. Parra [1 ]
Fernandez, A. Lara [1 ]
Nevado, A. Herencias [1 ]
Garcia, E. Baca [1 ]
机构：
[1] Hosp Univ Infanta Elena, Psychiat, Madrid, Spain
来源：
EUROPEAN PSYCHIATRY | 2023年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0758
引用
收藏
页码：S489 / S489
页数：1
相关论文
共 50 条
  • [1] Clinical experiences with 6-monthly paliperidone palmitate beyond the diagnosis of schizophrenia. A retrospective study
    Benavente Lopez, S.
    Bolano Mendoza, S.
    Parra Gonzalez, A.
    Lara Fernandez, A.
    Herencias Nevado, A.
    Baca Garcia, E.
    EUROPEAN PSYCHIATRY, 2023, 66 : S489 - S489
  • [2] Clinical experiences with 6-monthly paliperidone palmitate after 12 months of use. A retrospective study
    Benavente Lopez, S.
    Parra Gonzalez, A.
    Bolano Mendoza, S.
    Lara Fernandez, A.
    Herencias Nevado, A.
    Baca Garcia, E.
    EUROPEAN PSYCHIATRY, 2023, 66 : S488 - S488
  • [3] Alternative initiations with 6-monthly paliperidone palmitate. A retrospective study
    Benavente Lopez, S.
    Bolano Mendoza, S.
    Parra Gonzalez, A.
    Lara Fernandez, A.
    Herencias Nevado, A.
    Baca Garcia, E.
    EUROPEAN PSYCHIATRY, 2023, 66 : S488 - S489
  • [4] Paliperidone palmitate intramuscular 6-monthly formulation in schizophrenia: a profile of its use
    Hannah A. Blair
    Drugs & Therapy Perspectives, 2022, 38 : 335 - 342
  • [5] Paliperidone palmitate intramuscular 6-monthly formulation in schizophrenia: a profile of its use
    Blair, Hannah A.
    DRUGS & THERAPY PERSPECTIVES, 2022, 38 (08) : 335 - 342
  • [6] Alternative initiations with 6-monthly paliperidone palmitate. A descriptive study
    Sobrino, O. C.
    Sergio, B.
    EUROPEAN PSYCHIATRY, 2023, 66 : S1080 - S1080
  • [7] Alternative initiations with 6-monthly paliperidone palmitate. A descriptive study
    Sobrino, O. C.
    Sergio, B.
    EUROPEAN PSYCHIATRY, 2023, 66 : S1080 - S1080
  • [8] PATIENT EXPERIENCES WITH THREE-MONTHLY PALIPERIDONE PALMITATE FOR THE MANAGEMENT OF SCHIZOPHRENIA
    Brahmbhatt, P.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 120 - 121
  • [9] Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia
    Mathews, Maju
    Gopal, Srihari
    Nuamah, Isaac
    Hargarter, Ludger
    Savitz, Adam J.
    Kim, Edward
    Tan, Wilson
    Soares, Bernardo
    Correll, Christoph U.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 1365 - 1379
  • [10] Model-Informed Clinical Development of 6-Monthly Injection of Paliperidone Palmitate in Patients with Schizophrenia: Dosing Strategies Guided by Population Pharmacokinetic Modeling and Simulation (Part II)
    T'jollyn, Huybrecht
    Venkatasubramanian, Raja
    Neyens, Martine
    Gopal, Srihari
    Russu, Alberto
    Nandy, Partha
    Perez-Ruixo, Juan Jose
    Ackaert, Oliver
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (04) : 491 - 506
12345